Home / Insights / Why the Need for New Technology in Bio-pharma R&D?

insights-espresso-icon whitepaper

Why the Need for New Technology in Bio-pharma R&D?

Espresso-live Speakers
by Sarabjeet Singh Sharad
30 September 2013

Drug companies nowadays are focusing more on bio-pharma product development. Currently, there are close to 400 biotechnology drug products and vaccines in clinical trials, which are targeting more than 150 diseases. Companies need to manufacture their product candidate under current good manufacturing practice (cGMP) conditions to conduct clinical trials. R&D cost in bio-pharma is high and there is a need for more efficient technology as biologics manufacturing is complex and highly regulated by the FDA.

SHARE
Linkedin Twitter Facebook
Leave a comment

Please enter a valid name

Post your comment

Please select captcha

Instagram

Get more stories like this

Subscirbe for more news,updates and insights from Beroe

Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

Schedule a Demo Now